SYRE NASDAQ
Spyre Therapeutics, Inc.
1W: -1.8%
1M: +1.8%
3M: +72.0%
YTD: +143.0%
1Y: +382.6%
3Y: +1892.5%
5Y: -60.7%
$74.05
-0.27 (-0.36%)
Weekly Expected Move ±7.0%
$64
$70
$75
$80
$85
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
📊 Key Metrics
TTM$90M
Revenue
+0.0% YoY
$-179M
Net Income
+14.1% YoY
$-186M
Free Cash Flow
-9.4% YoY
0.0%
Gross Margin
0.0%
Op. Margin
0.0%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
⚠️ Cash Burn Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE-29.1%
ROA-25.9%
ROIC443.1%
Valuation
P/E-142.8
P/B38.2
EV/EBITDA-83.0
Leverage
Debt/Equity0.00
Current Ratio13.25
Interest Cov.0.0x
Quality Scores
Piotroski F3/9
Altman Z165.78
Beneish M0.00